by Scott King | Jan 15, 2021 | News
We may not be able to see it yet, but the impact of delays in early cancer detection techniques due to Covid-19 will have a direct impact on recovery rates and patient outcomes. With the NHS under immense pressure from the second wave of the pandemic, longer wait...
by Scott King | Jan 8, 2021 | News
Despite entering 2021 still fighting the coronavirus pandemic, the ongoing battle between Cancer and Covid-19 continues to rage behind the scenes, with Early Detection and treatment being delayed as the NHS struggles to cope with rising Covid-19 infection numbers and...
by Scott King | Dec 16, 2020 | News
RMDM Diagnostics appoints former NHS Confederation head as lead adviser for pan-cancer blood test. RMDM Diagnostics has appointed Mike Farrar CBE, former Chief Executive of the NHS Confederation, as lead adviser for its pan-cancer blood test, PanTum Detect. Mike will...
by Scott King | Nov 30, 2020 | News
November was extremely busy for us here at RMDM Group, as we saw a significant increase in demand for people wanting to take our popular cancer blood test. We are very fortunate to be working with Centre For Health and Human Performance in ensuring that cancer...
by Scott King | Sep 17, 2020 | News
A blood test that can accurately diagnose cancer at an early stage has long been the ‘holy grail’ of cancer diagnostics. Now, PanTum Detect is the blood test to offer non-invasive, reliable, and cost-effective cancer diagnosis – truly a revolution in cancer care!...
